Loading organizations...
§ Venture Capital · 33, Avenue du Maine Paris, Île-de-France 75015, FR
An organization for which specific details regarding its industry, services, and operational focus are currently unavailable.
Fa Di e is an organization operating in an undisclosed industry, with its specific business activities, core products, and primary headquarters location currently remaining unavailable in public market databases. Due to a lack of publicly disclosed financial filings, specific operational metrics such as total funding raised, assets under management, current enterprise valuation, employee headcount, or active user base cannot be independently verified at this time. The organization maintains a highly private corporate profile, meaning there are no confirmed associations with recognizable lead venture capital investors, notable portfolio companies, or major enterprise customers. Market intelligence platforms and regulatory registries currently lack comprehensive documentation regarding the entity's strategic initiatives, market positioning, or technological development roadmap. The exact founding year and the identities of the original founders of Fa Di e remain completely undisclosed to the broader market.
Fa Di e has 2 tracked investments across 2 companies. The latest tracked deal is $11.0M Series B in Pherecydes Pharma in January 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2018 | Pherecydes Pharma | $11.0M Series B | GO Capital | Karista, ACE Management, Auriga Partners, Omnes Capital, Participations Besancon |
| Jul 17, 2015 | InnaVirVax | $3.9M Other Equity | — | G1J ILE DE France, Catherine Boule, Paris Region Venture Fund, Christian Pradeyrol |